Leadership

Sandeep Laumas, M.D.
Executive Chairman
Sandeep Laumas
Dr. Laumas joined Private Innovate in 2014 as its executive chairman and as a member of its board of directors, and became our executive chairman and a member of our board of directors in connection with the completion of the Merger. In August 2007, Dr. Laumas founded Bearing Circle Capital, LP, an investment partnership, and has served as its managing director since such time. Dr. Laumas began his career at Goldman Sachs & Co. in 1996 as an equity analyst in the healthcare investment banking division working on mergers, acquisitions and corporate finance transactions before transitioning to the healthcare equity research division. After leaving Goldman Sachs Dr. Laumas moved to the buy side as an analyst at Balyasny Asset Management from 2001 to 2003. Dr. Laumas was a managing director of North Sound Capital from 2003 to 2007, where he was responsible for the global healthcare investment portfolio. From February 2011 to 2012, he was a member of the board of directors of Super Religare Laboratories Limited, Southeast Asia’s largest clinical laboratory service company. Dr. Laumas serves as an independent director on the board of directors of BioXcel Therapeutics, Inc. (Nasdaq: BTAI) and also served as a director of Parkway Holdings Ltd. (acquired by IHH Healthcare for $3 Billion: Singapore: IHH) from May through August 2010. Dr. Laumas received his A.B. in chemistry from Cornell University in 1990, M.D. from Albany Medical College in 1995, with a research gap year at the Dana-Farber Cancer Institute, and completed his medical internship in 1996 from the Yale University School of Medicine. We believe that Dr. Laumas’s prior board service and years of experience investing in the healthcare industry qualifies Dr. Laumas to serve on our board of directors.
Chairman of the Board
    Christopher P. Prior, Ph.D.
    Chief Executive Officer
    Christopher P. Prior, Ph.D.
    Dr. Prior is a recognized industry leader both as a developer of important new therapeutics and as an accomplished serial entrepreneur. Over the course of his 30-year career, he has generated more than 25 INDs and achieved four product approvals. In addition, he founded, built-up and sold two companies (Principia, BioRexis) in deal values exceeding $0.5 Billion. Chris joined Innovate in 2015 as Chief Executive Officer. Chris received a B.Sc. (honors) in chemistry from the University of London, a Ph.D. in biochemistry from Columbia University in New York City and a research fellowship at The Rockefeller Medical Institute (New York). Chris is a member of the New York Academy of Sciences and is the author of numerous publications and patents focused on the development of therapeutics.
      Jay P. Madan, M.S.
      Founder, President and Chief Business Officer
      Jay P. Madan
      Mr. Madan founded Private Innovate in 2012 and began serving as its president and as a member of its board of directors at such time, and he became our president and a member of our board of directors in connection with the completion of the Merger. In March 2018, Mr. Madan was also appointed as our chief business officer and serves as our interim principal financial officer and interim principal accounting officer. Prior to founding Private Innovate, Mr. Madan was an independent contractor advising multiple life sciences companies, including Reliance Life Sciences, Millipore, Baxter, Dade Behring and Goodwin. This experience in working across multiple teams led him to develop a global network of healthcare professionals. From July 2007 to November 2008, Mr. Madan served as the vice president of business development at Reliance Biopharmaceuticals Pvt. Ltd., a part of Reliance Industries Ltd., India's largest conglomerate. While at Reliance and Goodwin, Mr. Madan was focused on the development of their contract manufacturing businesses. Mr. Madan holds a B.S. in chemical engineering from University of Mumbai and an M.S. in chemical engineering from Washington State University. We believe that Mr. Madan's role as a founder of lnnovate and extensive experience in the life sciences and biotech industries qualifies him to serve on our board of directors.
      Financial Expert
        Kendyle Woodard, MBA
        Co-founder and Executive Vice President, Corporate Affairs

        Ms. Woodard co-founded Innovate Biopharmaceuticals in 2013 and has more than 15 years in business operations and marketing supporting startups, non-profits, manufacturers, and consulting companies. Ms. Woodard oversees the company’s operations and investor relations. She was the vice president of iBiotech working with clients on technology development, operations, marketing, and business development. Ms. Woodard assisted in the management and operations of several startup companies and with the commercialization of university technologies. As the Director of Marketing for the NC Biotechnology Center she positioned North Carolina as a world leader in life sciences to support the state’s economic development initiatives. Ms. Woodard earned her Bachelor of Science degree, magna cum laude, in international business and marketing from University of South Alabama and was awarded her Master of Business Administration degree, cum laude, from North Carolina State University. Ms. Woodard co-founded the Triangle chapter of Net Impact, is a past board member of the Women in Bio Triangle chapter, and currently serves as board chair of Adaptive Risk Systems, Inc.. Ms. Woodard is also a member of BIO’s Technology Transfer Committee.

          Copyright West LLC. Minimum 15 minutes delayed.